Skip to main content
SpringerLink
Log in

Computer Modelling

The Need for Careful Evaluation and Public Audit

  • Current Opinion
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sheldon TA. Problems of using modelling in the economic evaluation of health care. Health Econ 1996; 5: 1–11

    Article  PubMed  CAS  Google Scholar 

  2. Buxton M. Office of Health Economics Briefing; May 1997: No. 33

    Google Scholar 

  3. Duggan A. Modelling different approaches to the management of upper gastrointestinal disease in the United Kingdom. Pharmacoeconomics 1998; 14 Suppl. 2: 25–37

    Article  PubMed  Google Scholar 

  4. Whittaker M. Consensus guidelines for evaluating and treating patients with upper gastrointestinal symptoms in the primary care setting. Pharmacoeconomics 1998; 14 Suppl. 2: 5–10

    Article  Google Scholar 

  5. Haycox A. Butterworth M, Walley T, et al. Development of an economic model for the management of upper gastrointestinal disease in primary care: preliminary findings. Pharmacoeconomics 1998; 14 Suppl. 2: 11–23

    Article  PubMed  Google Scholar 

  6. Tosetti C, Stanghellini V. Management of dyspepsia in general practice: a critical assessment. Pharmacoeconomics 1998; 14 Suppl. 2: 57–66

    Article  PubMed  Google Scholar 

  7. Gotzstche PC. Methodology and overt and hidden bias in reports of 196 double blind trials of NSAIDs in rheumatoid arthritis. Control Clin Trials 1989; 10: 31–56

    Article  Google Scholar 

  8. Bailar JC. The promise and problems of meta analysis. N Engl J Med 1997; 337 (8): 559–60

    Article  PubMed  Google Scholar 

  9. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665–73

    Article  PubMed  CAS  Google Scholar 

  10. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995; 310: 1433–8

    Article  PubMed  CAS  Google Scholar 

  11. Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683–7

    Article  PubMed  CAS  Google Scholar 

  12. Glick H, Heyse JF, Thompson P, et al. A model for evaluating the cost effectiveness of cholesterol lowering treatment. Int J Technol Assess Health Care 1992; 8: 719–34

    Article  PubMed  CAS  Google Scholar 

  13. Feinstein AR. Meta-analysis: statistical alchemy of the 21st century. J Clin Epidemiol 1995; 48: 71–9

    Article  PubMed  CAS  Google Scholar 

  14. Concorde Co-ordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343: 871–81

    Article  Google Scholar 

  15. Herroro L. Pharmacoeconomics — exploring the modelling option. Scrip Oct 1994: 42–5

    Google Scholar 

  16. Good clinical practice for trials on medicinal products in the European community. Brookwood Medical Publications Ltd 1993, ISBN 1-874409-30-7

  17. Data on file, Janssen-Cilag Ltd. Barrow D: Pegasus Healthcare Ltd, Mar 1997

  18. Data on file, Janssen-Cilag Ltd. Guest JF: Catalyst Healthcare Ltd, Sep 1997

  19. Kassirer JP, Angell M. The journal’s policy on cost-effectiveness analyses [editorial]. N Engl J Med 1994; 331: 669–70

    Article  PubMed  CAS  Google Scholar 

  20. Drummond MF, Jefferson TO, on behalf of the BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275–83

    Article  PubMed  CAS  Google Scholar 

  21. Buxton MJ, Drummond MF, VanHout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6 (3): 217–28

    Article  PubMed  CAS  Google Scholar 

  22. Gold MR, Siegel JE, Russell LB, et al. Cost effectiveness in health and medicine. New York: Oxford University Press, 1986

    Google Scholar 

  23. Drummond MF, O’Brien B, Stoddart GL, et al. Methods of economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997

    Google Scholar 

  24. Maynard A. Economic evaluation techniques in healthcare: reinventing the wheel? Pharmacoeconomics 1997; 11 (2): 115–8

    Article  PubMed  CAS  Google Scholar 

  25. Reinhardt UE. Making economic evaluations respectable. Soc Sci Med 1997; 45 (4) 555–62

    Article  PubMed  CAS  Google Scholar 

  26. Maynard A. Economic evaluation techniques in healthcare: reinventing the wheel? The author’s reply. Pharmacoeconomics 1997; 12 (4): 505–6

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. York Health Economics Consortium, The University of York, Heslington, York, YO1 5DD, England

    Alan Maynard

  2. Janssen-Cilag Ltd, High Wycombe, Buckinghamshire, England

    R. F. Cookson

Authors
  1. Alan Maynard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. F. Cookson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan Maynard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maynard, A., Cookson, R.F. Computer Modelling. Pharmacoeconomics 14 (Suppl 2), 67–72 (1998). https://doi.org/10.2165/00019053-199814002-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199814002-00007

Keywords

Search

Navigation